Related Experiment Video
Updated: May 26, 2026
09:48
Monitoring of Nanodrug Accumulation in Murine Breast Cancer Metastases
Published on: August 23, 2024
Monoenomycin: A Simplified Trienomycin A Analogue that Manifests Anticancer Activity
Gary E L Brandt1, Brian S J Blagg
1Department of Medicinal Chemistry, 1251 Wescoe Hall Drive, Malott 4070, The University of Kansas, Lawrence, Kansas 66045-7563.
ACS Medicinal Chemistry Letters
|December 14, 2011
Summary
Macrocyclic natural products, like trienomycin A, show promise in drug discovery. Researchers designed a simplified analogue, monoenomycin, with potent anticancer activity, overcoming synthetic challenges.
Area of Science:
- Natural Product Chemistry
- Medicinal Chemistry
- Drug Discovery
Background:
- Macrocyclic natural products often exhibit favorable drug-like properties despite violating Lipinski's rule of 5.
- Their complex structures pose synthetic challenges, hindering analogue development for drug discovery.
- Ansamycin natural products, including trienomycin A, are known for potent anticancer activity.
Purpose of the Study:
- To design and synthesize simplified analogues of trienomycin A.
- To rapidly identify essential structural components for biological activity.
- To explore novel anticancer agents derived from macrocyclic natural products.
Main Methods:
- A conformation-based approach was employed.
- Structure-activity relationship (SAR) studies were integrated with molecular modeling.
- Simplified analogues of trienomycin A were synthesized concisely.
Main Results:
- A novel trienomycin A analogue, named monoenomycin, was successfully designed and synthesized.
- Monoenomycin demonstrated potent anticancer activity.
- The study identified key structural features necessary for biological efficacy.
Conclusions:
- Simplified macrocyclic analogues can be effectively developed using conformation-based strategies.
- Monoenomycin represents a promising lead compound for anticancer drug development.
- This approach facilitates the exploration of complex natural products in drug discovery programs.
More Related Videos
11:00Methods to Inhibit Bacterial Pyomelanin Production and Determine the Corresponding Increase in Sensitivity to Oxidative Stress
Published on: August 31, 2015
09:00An In Vitro Enzymatic Assay to Measure Transcription Inhibition by Gallium(III) and H3 5,10,15-tris(pentafluorophenyl)corroles
Published on: March 18, 2015
Related Concept Videos
01:10Drugs that Destabilize Microtubules
Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
01:25Inhibitors of Bacterial Protein Synthesis
Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...
01:15Drugs that Stabilize Microtubules
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
01:27Combined Effects of Drugs: Synergism
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
01:28Inhibitors of Bacterial DNA Synthesis
Bacterial pathogens depend on precise and efficient DNA replication to sustain infection. Two type II topoisomerases—DNA gyrase and topoisomerase IV—are critical to this process, as they resolve DNA supercoiling and unlink chromosomes during replication. Fluoroquinolones, synthetic derivatives of quinolones, exploit this mechanism by stabilizing the transient DNA–enzyme cleavage complex, preventing strand religation, and causing lethal double-strand breaks. These antibiotics are selectively...